OLAPARIB Tablets

Active substance -: Olaparib Tablet
Dosage Forms & Strengths: 100mg Tablet & 150mg Tablet

Available Brand Names for “Olaparib Tablets” In India

BRACANAT 100, 150 mg Tablet	NATCO
LYNPARZA 100, 150 mg Tablet	AstraZeneca
BDPARP 100, 150 mg Tablet	BDR Pharmaceuticals

Procedure for Delivery Request:
For more information on products or how to order you can submit an online request or reach us on the given contact details, we will get back to you shortly.

We distribute a diverse range of pharmaceutical drugs, catering to the entirety of the pharmaceutical trade, which includes wholesale, tender supplies, orphan drugs, named patient access, biologics, biosimilars, and vaccines.

Categories Cytotoxic Drugs, Oncology, Ovarian cancer

For Overseas Patient / Export Inquires.

Alleviare specialize in delivering pharmaceutical supplies domestically and internationally. With a customer base exceeding 250 satisfied clients across 65 countries at competitive prices. For your next order of generic drugs, please reach out to us.

Call Us

+91 9643240915 (Mr. Yashpal Singh) +91 9289711087 (Ms. Sana Sadyar)

Email Us

alleviare.exports@gmail.com sana.sadyar@alleviareindia.com

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Description

Description

Olaparib is a targeted drug used in maintenance treatment of a number of cancers. Especially Advanced Ovarian Cancer in adults. It prevents PARP, a protein repairing DNA damage in order to get rid of cancer cells. You might have it by itself or in combination with another cancer drug as prescribed by your physician.

Olaparib was first launched by Astrazeneca under the brand name of Lynparza in the form of 100mg & 150mg Tablets. Now some Indian multinational companies such as Natco and BDR pharmaceuticals, offer cost effective biosimilar alternatives in India.

Olaparib Tablet – Drug Information

Drug : LYNPARZA, BRACANAT, BDPARPi
Pharmacological Classification: PARP inhibito
Therapeutic Indication: Ovarian Cancer
Dosage Forms & Strengths: capsule: Capsules 40mg / tablet: 40mg, 80mg
Hsn Code: 30044090

About Us

Alleviare Life Sciences private limited India, specializes in the Global Export of all Specialty Drugs, including Vaccines & Cold Chain Pharma Products, and General Pharmaceutical Products to our customers. We don’t process requests for Schedule X and other habit-forming drugs.

We also provide consulting services to Indian patients for medicines that are not available/registered in India. Assisting patients with documentation, logistics and procurement of such medicines from international authorised suppliers/distributors.

We are also present globally as marketing & distribution company, operating in southeast Asia pacific region as Alleviare Life Sciences Limited.

We have shipped to:

We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.

Opening Hours:
Monday – Saturday 10am – 6pm
Email –
bd@alleviareindia.com
contact@alleviareindia.com

Contact Address:
P: 011: 35017784 / 35017785
M/W: +91 9289711087 / 9289711088

Address:
Mezzanine Floor, S-9, Green Park Extension, South Delhi, Delhi, 110016

DISCLAIMER: All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks. 1. In compliance with Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. 2. We don’t process requests for Schedule X and other habit-forming drugs.

Terms and Conditions | Privacy Policy | Disclaimer

OLAPARIB Tablets